Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
---|
10/17/2002 | US20020150577 Transforming growth factor; transgenic animal; increas ratios of muscle mass |
10/17/2002 | CA2446462A1 Chimeric vaccines |
10/17/2002 | CA2443275A1 Improved gene expression |
10/17/2002 | CA2442092A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication |
10/17/2002 | CA2441638A1 Experimental animals for evaluation of therapeutic effects on corneal epithelial damages |
10/16/2002 | EP1249160A1 Model animal with favorite onset of rheumatoid arthritis |
10/16/2002 | EP1248852A2 Method of assessing the viability of a cell |
10/16/2002 | EP1248847A1 Irak-4: compositions and methods of use |
10/16/2002 | EP1248518A2 Transgenic mouse model of human neurodegenerative disease |
10/16/2002 | EP1248517A2 Clonal propagation of primate offspring by embryo splitting |
10/16/2002 | EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
10/16/2002 | EP0619742B1 Transfection of lung via aerosolized transgene delivery |
10/15/2002 | US6465715 Dna fragments from the promoter region of the c. elegans ul6 gene which are capable of functioning as promoters directing gene expression in the excretory cell of c. elegans are provided and also expression vectors and transgenic c. elegans |
10/15/2002 | US6465714 Congenic animal models of non-insulin dependent diabetes mellitus |
10/15/2002 | US6465254 Nucleotide sequence (loxp site) where in the presence of recombinase cre, recombination with a wild-type loxp site can not occur, and recombination between two mutant loxp sites having the identical sequence occur; gene transfer |
10/15/2002 | US6465239 Genetically engineered chromosomes in germ cells; high protein and muscle foods |
10/10/2002 | WO2002079481A1 Method of encoding information in nucleic acids of a genetically engineered organism |
10/10/2002 | WO2002079480A1 Gfp expression vector localized in mitochondria |
10/10/2002 | WO2002079478A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders |
10/10/2002 | WO2002079447A2 Avian lysozyme promoter |
10/10/2002 | WO2002079441A2 Secreted proteins |
10/10/2002 | WO2002079419A2 Identifying and characterizing genes |
10/10/2002 | WO2002079418A2 Gene regulation ii |
10/10/2002 | WO2002079416A2 Transgenic animals resistant to transmissible spongiform encephalopathies |
10/10/2002 | WO2002079238A2 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
10/10/2002 | WO2002079230A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
10/10/2002 | WO2002078640A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
10/10/2002 | WO2002078434A1 Murine model of dermatitis |
10/10/2002 | WO2002078432A1 Products and methods for improving animal dental hygiene |
10/10/2002 | WO2002033047A3 In vitro embryo culture device |
10/10/2002 | WO2002026820A3 Immunomodulatory protein derived from the yaba monkey tumor virus |
10/10/2002 | WO2002014495B1 Enhanced homologous recombination mediated by lambda recombination proteins |
10/10/2002 | US20020148000 HS-40 enhancer-containing vector in transgenic animals |
10/10/2002 | US20020147999 Reducing neuronal tangles in alzhemier's patients; obtain human, administer modulator, monitor development of neuronal tangles in, reduction in neuronal tangles indicates modulator |
10/10/2002 | US20020147997 Animal model for use in the diagnosis, prevention and treatment of cancer |
10/10/2002 | US20020147327 Glucocorticoid receptor protein for use in the treatment of arthritis and asthma |
10/10/2002 | US20020147305 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
10/10/2002 | US20020147162 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (PTTG) |
10/10/2002 | US20020146806 Nucleotide sequences coding polypeptides for use in the treatment of rheumatic and autoimmune diseases |
10/10/2002 | US20020146797 Genetically engineered enzyme for use in the treatment of cell proliferative disorders |
10/10/2002 | US20020146792 Nucleotide sequences coding protein for use in the treatment of atherosclerosis |
10/10/2002 | US20020146773 ''Signalin'' family of TGFbeta signal transduction proteins, and uses related thereto |
10/10/2002 | US20020146768 Apoliprotein for use in treatment of stroke, heart defects, reperfusion injuries, viral, nervous system, vision and blood disorders |
10/10/2002 | US20020144658 Solids discharge device |
10/10/2002 | DE10115507A1 Verfahren zur Kodierung von Information in Nukleinsäuren eines genetisch veränderten Organismus The process of encoding information in nucleic acids of a genetically modified organism |
10/10/2002 | CA2442847A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
10/10/2002 | CA2442684A1 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
10/10/2002 | CA2442062A1 Secreted proteins |
10/10/2002 | CA2442022A1 Method of encoding information in nucleic acids of a genetically engineered organism |
10/09/2002 | EP1248111A2 Kit and method for diagnosing non-pregnancy |
10/09/2002 | EP1246927A2 Biological control by conditional dominant lethal genetic system |
10/09/2002 | EP1246918A2 Secreted proteins |
10/09/2002 | EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
10/09/2002 | EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof |
10/09/2002 | EP0979277A4 Novel human tumour suppressor gene |
10/09/2002 | EP0833620B1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
10/09/2002 | CN1372792A Technique for taking toxin from spider |
10/09/2002 | CN1372791A Method for clturing transgenic fowls |
10/08/2002 | US6462254 Detecting gene expression of fusion proteins |
10/08/2002 | US6461864 Inserting dna construct into pluripotent cell comprising heterologous dna; genetic engineering |
10/08/2002 | US6461850 Peptides selected by homology and/or structural relatedness to known protease proteins of the choriolytic hatching protease subfamily and expression pattern observed |
10/08/2002 | US6461846 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects |
10/08/2002 | US6461818 Method for chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpoints |
10/03/2002 | WO2004031223A1 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
10/03/2002 | WO2002077637A1 Sex-specific selection of sperm from transgenic animals |
10/03/2002 | WO2002077267A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
10/03/2002 | WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same |
10/03/2002 | WO2002077263A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
10/03/2002 | WO2002077261A2 Human potassium channel |
10/03/2002 | WO2002077218A1 Coagulation factor vii derivatives |
10/03/2002 | WO2002077213A2 New elongase gene and production of δ9-polyunsaturated fatty acids |
10/03/2002 | WO2002077211A2 A virus (cryptovirus) within the rubulavirus genus and uses therefor |
10/03/2002 | WO2002077175A2 Method for generating cloned animals using chromosome shuffling |
10/03/2002 | WO2002077168A2 Mch1r deficient mice |
10/03/2002 | WO2002077161A2 Production of high levels of trangenic factor ix without gene rescue, and its therapeutic uses |
10/03/2002 | WO2002077027A1 Human stra6-like protein and nucleic acids encoding the same |
10/03/2002 | WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
10/03/2002 | WO2002076195A1 Ras p27 animal models and uses thereof |
10/03/2002 | WO2002076190A2 Incorporation of competitive effects in breeding program to increase performance levels and improve animal well being |
10/03/2002 | WO2002029086A3 Nucleic acid sequences differentially expressed in cancer tissue |
10/03/2002 | WO2002026193A3 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
10/03/2002 | WO2002014494A3 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed |
10/03/2002 | WO2001094627A3 Assay techniques based on growth stage dependent expression in c. elegans |
10/03/2002 | WO2001071004A3 Proteases |
10/03/2002 | WO2001019846A9 Transgenically produced fusion proteins |
10/03/2002 | WO2001017343A9 Methods for evaluating a compound for its effect on skin |
10/03/2002 | WO1999064459A3 Gene encoding organic anion transporter |
10/03/2002 | US20020144301 Animal model for use in the diagnoois and treatment of prostate cancer |
10/03/2002 | US20020144299 Nuceotide sequences coding malarial surface protein for use in the treatment and prevention of malaria |
10/03/2002 | US20020144296 Transgenic animal for use in the generation of heterologous proteins in milk; for use in generation of disease and infection resistant pigs |
10/03/2002 | US20020142988 G-coupled receptor showing selective affinity for ATP |
10/03/2002 | US20020142456 Protein for use in the treatment of body weight defects |
10/03/2002 | US20020142430 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
10/03/2002 | US20020142418 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
10/03/2002 | US20020142378 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
10/03/2002 | US20020142359 Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system |
10/03/2002 | US20020142338 Compositions and methods for inhibiting motor neuron degeneration |
10/03/2002 | US20020142283 Inhibitors of C-reactive protein induced inflammation |
10/03/2002 | CA2443676A1 A novel modulator of non-genomic activity of nuclear receptors (mnar) and uses thereof |
10/03/2002 | CA2442089A1 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |